"10.1371_journal.pone.0063491","plos one","2013-05-09T00:00:00Z","Anujith Kumar; Antonio Lo Nigro; Conny Gysemans; Qing Cai; Camila Esguerra; Molly Nelson-Holte; Yves Heremans; María Jiménez-González; Angelo Porciuncula; Chantal Mathieu; Bert Binas; Harry Heimberg; Felipe Prosper; Bernhard Hering; Catherine M Verfaillie; Miguel Barajas","Stamcel Instituut Leuven, Katholieke Universiteit Leuven, Leuven, Belgium; Laboratory for Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium; Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America; Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium; Hematology and Cell Therapy, Clinica Universidad de Navarra and Foundation for Applied Medical Research, Division of Oncology, University of Navarra, Pamplona, Spain; Division of Molecular & Life Science, College of Science and Technology, Hanyang University, Ansan, South Korea; Diabetes Institute for Immunology and Transplantation. University of Minnesota, Minneapolis, Minnesota, United States of America; Manipal Institute of Regenerative Medicine, Domlur, Bangalore, India","Conceived and designed the experiments: AK CG QC CE YH MB. Performed the experiments: AK CG QC CE MNH MJG AP MB. Analyzed the data: AK CG QC AL MB. Contributed reagents/materials/analysis tools: AK CG CE MNH AL MB. Wrote the paper: AK AP CM BB HH FP BH CMV MB.","Dr. Felipe Prosper is currently an editor for PLOS ONE. Regarding Dr. Felipe Prosper as being a member of the PLOS ONE Editorial Board, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Anujith Kumar","AK",16,TRUE,6,8,5,9,TRUE,TRUE,FALSE,0,NA,FALSE
